新冠肺炎与肿瘤化疗患者外周血线特征的关系

Jia-Yong Su
{"title":"新冠肺炎与肿瘤化疗患者外周血线特征的关系","authors":"Jia-Yong Su","doi":"10.14744/ejmo.2023.18762","DOIUrl":null,"url":null,"abstract":"Objectives: Future pandemics involving COVID-19 or other respiratory disorders may pose risks to treatment outcomes among cancer patients on chemotherapy. Here we explored whether diagnosis with COVID-19 might influence how chemotherapy alters the peripheral hemogram of cancer patients. To examine changes in the peripheral hemo-gram before and after chemotherapy depending on whether patients were unexposed to the SARS-CoV-2 virus, had COVID-19, or were recovering from COVID-19. Methods: We retrospectively reviewed the records of 8,900 patients with solid cancers who underwent chemotherapy between October 10, 2022 and March 1, 2023. We compared hemograms before and after chemotherapy within and across the following three groups: 3,215 patients previously unexposed to SARS-CoV-2, 2,771 patients with COVID-19, and 2,817 patients recovering from COVID-19. We compared counts of white blood cells, red blood cells, and platelets as well as percentages of neutrophils between the first blood sampling after admission and the first sampling after conclusion of chemotherapy. Results: Of the various parameters examined, only the changes in counts of white blood cells and platelets differed significantly across the three patient groups. White blood cell count before chemotherapy was lower in patients with COVID-19 than in those unexposed to the virus or those recovering from COVID-19. Platelet count after chemotherapy was lower in patients with COVID-19 than in those recovering from COVID-19. Chemotherapy reduced the red blood cell count and increased the neutrophil percentage in all three patient groups, with the largest changes occurring in patients with COVID-19; however, these changes did not achieve statistical significance. Conclusion: These studies suggest that COVID-19 does not significantly alter the peripheral hemogram of cancer patients who receive effective chemotherapy.","PeriodicalId":11831,"journal":{"name":"Eurasian Journal of Medicine and Oncology","volume":"20 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Association of COVID-19 with Features of the Peripheral Hemogram Among Cancer Patients Undergoing Chemotherapy\",\"authors\":\"Jia-Yong Su\",\"doi\":\"10.14744/ejmo.2023.18762\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objectives: Future pandemics involving COVID-19 or other respiratory disorders may pose risks to treatment outcomes among cancer patients on chemotherapy. Here we explored whether diagnosis with COVID-19 might influence how chemotherapy alters the peripheral hemogram of cancer patients. To examine changes in the peripheral hemo-gram before and after chemotherapy depending on whether patients were unexposed to the SARS-CoV-2 virus, had COVID-19, or were recovering from COVID-19. Methods: We retrospectively reviewed the records of 8,900 patients with solid cancers who underwent chemotherapy between October 10, 2022 and March 1, 2023. We compared hemograms before and after chemotherapy within and across the following three groups: 3,215 patients previously unexposed to SARS-CoV-2, 2,771 patients with COVID-19, and 2,817 patients recovering from COVID-19. We compared counts of white blood cells, red blood cells, and platelets as well as percentages of neutrophils between the first blood sampling after admission and the first sampling after conclusion of chemotherapy. Results: Of the various parameters examined, only the changes in counts of white blood cells and platelets differed significantly across the three patient groups. White blood cell count before chemotherapy was lower in patients with COVID-19 than in those unexposed to the virus or those recovering from COVID-19. Platelet count after chemotherapy was lower in patients with COVID-19 than in those recovering from COVID-19. Chemotherapy reduced the red blood cell count and increased the neutrophil percentage in all three patient groups, with the largest changes occurring in patients with COVID-19; however, these changes did not achieve statistical significance. Conclusion: These studies suggest that COVID-19 does not significantly alter the peripheral hemogram of cancer patients who receive effective chemotherapy.\",\"PeriodicalId\":11831,\"journal\":{\"name\":\"Eurasian Journal of Medicine and Oncology\",\"volume\":\"20 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Eurasian Journal of Medicine and Oncology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.14744/ejmo.2023.18762\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Eurasian Journal of Medicine and Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14744/ejmo.2023.18762","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

本文章由计算机程序翻译,如有差异,请以英文原文为准。
Association of COVID-19 with Features of the Peripheral Hemogram Among Cancer Patients Undergoing Chemotherapy
Objectives: Future pandemics involving COVID-19 or other respiratory disorders may pose risks to treatment outcomes among cancer patients on chemotherapy. Here we explored whether diagnosis with COVID-19 might influence how chemotherapy alters the peripheral hemogram of cancer patients. To examine changes in the peripheral hemo-gram before and after chemotherapy depending on whether patients were unexposed to the SARS-CoV-2 virus, had COVID-19, or were recovering from COVID-19. Methods: We retrospectively reviewed the records of 8,900 patients with solid cancers who underwent chemotherapy between October 10, 2022 and March 1, 2023. We compared hemograms before and after chemotherapy within and across the following three groups: 3,215 patients previously unexposed to SARS-CoV-2, 2,771 patients with COVID-19, and 2,817 patients recovering from COVID-19. We compared counts of white blood cells, red blood cells, and platelets as well as percentages of neutrophils between the first blood sampling after admission and the first sampling after conclusion of chemotherapy. Results: Of the various parameters examined, only the changes in counts of white blood cells and platelets differed significantly across the three patient groups. White blood cell count before chemotherapy was lower in patients with COVID-19 than in those unexposed to the virus or those recovering from COVID-19. Platelet count after chemotherapy was lower in patients with COVID-19 than in those recovering from COVID-19. Chemotherapy reduced the red blood cell count and increased the neutrophil percentage in all three patient groups, with the largest changes occurring in patients with COVID-19; however, these changes did not achieve statistical significance. Conclusion: These studies suggest that COVID-19 does not significantly alter the peripheral hemogram of cancer patients who receive effective chemotherapy.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
5.60
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信